JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ningaraj, N. S.
Right arrow Articles by Black, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ningaraj, N. S.
Right arrow Articles by Black, K. L.

Vol. 301, Issue 3, 838-851, June 2002

Regulation of Blood-Brain Tumor Barrier Permeability by Calcium-Activated Potassium Channels

Nagendra S. Ningaraj, Mamatha Rao, Kazuhiro Hashizume1 , Kamlesh Asotra and Keith L. Black

Maxine Dunitz Neurosurgical Institute and Burns and Allen Research Institute (N.N.,M.R.,K.H.,K.B.), Confocal Microscopy Facility, and Atherosclerosis Research Center, Division of Cardiology (K.A.), Cedars-Sinai Medical Center, Los Angeles, California

The blood-brain tumor barrier (BTB) limits the delivery of therapeutic drugs to brain tumors. We demonstrate in a rat brain tumor (RG2) model an enhanced drug delivery to brain tumor following intracarotid infusion of bradykinin (BK), nitric oxide (NO) donors, or agonists of soluble guanylate cyclase (sGC) and calcium-dependent potassium (KCa) channels. We modulated KCa channels by specific agonists and agents that produce NO and cGMP in situ to obtain sustained enhancement of selective drug delivery to brain tumors. Intracarotid infusion of BK or 1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one (NS-1619) significantly enhanced BTB permeability (Ki) to [14C]alpha -aminoisobutyric acid in the brain tumor area but not in normal brain tissue. The Ki increase achieved by BK, NS-1619, NO donors, or the sGC activator 3-(5'-hydroxymethyl-2'furyl)-1-benzylindazole (YC-1) was significantly attenuated when coinfused with a KCa channel antagonist, iberiotoxin. Immunoblot and immunolocalization studies demonstrate overexpression of KCa channels in tumor cells and capillaries compared with normal brain. The potentiometric assays demonstrate the functional activity of KCa channels in rat brain endothelial and glioma cells. Additionally, we show that BK and NS-1619 significantly increased the density of transport vesicles in the cytoplasm of brain tumor capillary endothelia and tumor cells. The cleft indices and cleft area indices in rat tumor capillaries were significantly higher than in normal brain capillaries, and BK infusion did not alter these indices. These data demonstrate that the cellular mechanism for KCa channel-mediated BTB permeability increase is due to accelerated formation of pinocytotic vesicles, which can transport drugs across BTB. We conclude that KCa channels serve as a convergence point in the biochemical regulation of BTB permeability.


1 Present address: Yamanashi Medical University, Department of Neurosurgery, Nakakoma-gun, Yamanashi Prefecture, Japan 409-3898


0022-3565/02/3013-0838$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
D. Yin, X. Wang, B. M. Konda, J. M. Ong, J. Hu, M. R. Sacapano, M. K. Ko, A. J. Espinoza, D. K. Irvin, Y. Shu, et al.
Increase in Brain Tumor Permeability in Glioma-Bearing Rats with Nitric Oxide Donors
Clin. Cancer Res., June 15, 2008; 14(12): 4002 - 4009.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Weaver, M. L. Olsen, M. B. McFerrin, and H. Sontheimer
BK Channels Are Linked to Inositol 1,4,5-Triphosphate Receptors via Lipid Rafts: A NOVEL MECHANISM FOR COUPLING [Ca2+]i TO ION CHANNEL ACTIVATION
J. Biol. Chem., October 26, 2007; 282(43): 31558 - 31568.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Yamazaki, M. Aoyama, S. Ohya, K. Muraki, K. Asai, and Y. Imaizumi
Novel Functions of Small Conductance Ca2+-activated K+ Channel in Enhanced Cell Proliferation by ATP in Brain Endothelial Cells
J. Biol. Chem., December 15, 2006; 281(50): 38430 - 38439.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. S. Ningaraj, M. K. Rao, and K. L. Black
Adenosine 5'-triphosphate-sensitive Potassium Channel-mediated Blood-Brain Tumor Barrier Permeability Increase in a Rat Brain Tumor Model
Cancer Res., December 15, 2003; 63(24): 8899 - 8911.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.